Interventional Cardiology Devices Market worth $42.39 billion by 2031
The report "Interventional Cardiology Devices Market by Type [Stents (Drug-eluting Stent, Bare Metal Stent), Catheters (Angiography, Guiding, IVUS/OCT Catheters), Balloons, Plaque Modification Devices, Hemodynamic Flow Alteration], End User - Global Forecast to 2031” is projected to grow from USD 31.12 billion in 2026 and to reach USD 42.39 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 6.4% during the forecast period.
Browse 380 market data Tables and 65 Figures spread through 400 Pages and in-depth TOC on "Interventional Cardiology Devices Market by Type [Stents (Drug-eluting Stent, Bare Metal Stent), Catheters (Angiography, Guiding, IVUS/OCT Catheters), Balloons, Plaque Modification Devices, Hemodynamic Flow Alteration], End User - Global Forecast to 2031”
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html
An increase in heart-related diseases, such as coronary artery disease and structural heart disorders, worldwide has been the major driver of the global market for interventional cardiology devices; this is mainly due to the aging population, sedentary lifestyles, and the growing number of diabetes and obesity cases. The market is fueled by the faster acceptance of less invasive catheter-based surgeries, which offer shorter hospital stays and fewer complications. Technological innovations, including next-generation drug-eluting stents, transcatheter heart valves, intravascular imaging technologies (IVUS/OCT), and physiology-guided diagnostics, are making procedures more accurate and expanding the number of clinical indications. Developing countries are also supporting market growth through increased healthcare expenditure, expansion of catheterization laboratories, and improved access to advanced cardiac care. Developed countries' favorable reimbursement policies and general awareness of early diagnosis and interventional treatment are adding to the market's growth in the long run, which is why the global interventional cardiology devices market continues to grow.
“Based on angioplasty stents, the drug-eluting stents segment is expected to grow at the highest CAGR during the forecast period.”
The rise in the number of drug-eluting stents (DES) in the global interventional cardiology devices market can be attributed to the ever-increasing prevalence of coronary artery disease and the growing number of percutaneous coronary interventions worldwide. This trend is particularly noticeable among older people, diabetes patients, and those with very complex lesions. Also, there are strong papers that show that stents are favored by doctors because of their lower rates of restenosis and repeat revascularization compared to bare-metal stents. Moreover, the advancements in technology are now even more powerful than before, and they include thinner stents, better polymer coatings, polymer-free and bioresorbable platforms, and antiproliferative drugs with improved formulations. These developments are making the implants safer and more successful in the long term, and this aspect is also favoring the implantation. In addition, the underlying drivers of the production of drug-eluting stents worldwide are broader access to catheterization laboratories in the developing world, more extensive reimbursement coverage in developed regions, and the growing use of DES in complex and multivessel procedures. These factors are all contributing to the sustained global demand for drug-eluting stents.
“The angiography catheters segment is expected to account for the largest share, by catheters, in the interventional cardiology devices market.”
The adoption of angiography catheters in the worldwide interventional cardiology devices market is primarily driven by the prevalence of cardiovascular and peripheral vascular diseases, which has increased the number of diagnostic and interventional angiographic procedures performed worldwide. In addition, the acceptance of minimally invasive cardiac interventions guided by imaging is escalating demand for angiography catheters with better deliverability, torque control, and optimal contrast injection. Product innovations, such as hydrophilic coatings, new tip designs, and improved compatibility with modern imaging systems, are also making procedures more efficient and safer. Moreover, the rise in the number of catheterization labs, increasing healthcare investments, and better access to advanced diagnostic infrastructure in developing countries are contributing to market growth. Additionally, the rising use of angiography for early disease detection, procedural planning, and follow-up assessment is driving global demand for angiography catheters.
“Based on end user, the ambulatory surgery centers account for the second largest share in the interventional cardiology devices market.”
One of the prominent factors behind the growth of ambulatory surgical centers (ASCs) as an end-user sector in the overall interventional cardiology devices market is the steady transition toward outpatient and same-day cardiac procedures, which are made possible by the continuous improvement of minimally invasive interventional technologies. ASCs are widely recognized for their advantages over hospital settings—their cost-effectiveness, shorter procedure times, and quicker patient recovery—making them suitable for low- to moderate-risk interventional cardiology interventions. Progress in device safety, smaller catheter diameters, and better imaging guidance has led to a wider spectrum of cardiology interventions that can be performed in ASCs. Moreover, favorable reimbursement policies for outpatient procedures in developed countries, increasing patient willingness to choose the most convenient care settings, and rising investments in ASC infrastructure and capabilities are all accelerating the global adoption of interventional cardiology devices in ambulatory surgical centers.
Key Market Players
Some of the prominent players operating in the interventional cardiology devices market include Boston Scientific Corporation (US), Medtronic (US), Abbott (US), B. Braun SE (Germany), Terumo Corporation (Japan), Edwards Lifesciences Corporation (US), Koninklijke Philips N.V. (Netherlands), Integer Holdings Corporation (US), Teleflex Incorporated (US), Penumbra, Inc. (US), Cook (US), Cordis (US), iVascular S.L.U (Spain), Biosensors International Group, Ltd (Singapore), BIOTRONIK SE & Co. KG (Germany).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Interventional Cardiology Devices Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
